Epidiolex (Cannabidiol) for EpilepsyJune 26, 2018
Epidiolex is an oral liquid formulation of a highly purified extract of cannabidiol (CBD). CBD is a non-psychoactive component of Cannabis sativa (marijuana) that has demonstrated anticonvulsant activity in preclinical models of epilepsy. It is approved by the Food and Drug Administration for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome in patients 2 years of age and older.
If you have a Hayes login, click here to view the full report on the Knowledge Center.